Racial disparities in the pathogenesis of type 2 diabetes and its subtypes in the african diaspora: A new paradigm

Journal of Racial and Ethnic Health Disparities

Volumn 3, Issue 1, 2015, Pages 117-128

  Gaillard, Trudy R ^a   Osei, Kwame ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

African diaspora; Insulin resistance; Insulin secretion; Ketosis prone diabetes; Type 2 diabetes

Indexed keywords

AFRICA SOUTH OF THE SAHARA; BLACK PERSON; CAUCASIAN; EPIDEMIOLOGY; ETHNOLOGY; HEALTH DISPARITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE; STATISTICS AND NUMERICAL DATA;

AFRICA SOUTH OF THE SAHARA; AFRICAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEALTH STATUS DISPARITIES; HUMANS; INSULIN RESISTANCE; PREVALENCE;

EID: 85015343641     PISSN: 21973792     EISSN: 21968837     Source Type: Journal    
DOI: 10.1007/s40615-015-0121-z     Document Type: Article

References (76)

1. Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011; 378 (9785): 31–40.
2. Yisahak SF, Beagley J, Hambleton IR, Narayan KM, IDF Diabetes Atlas. Diabetes in North America and the Caribbean: an update. Diabetes Res Clin Pract. 2014; 103 (2): 223–30.
3. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011; 94 (3): 311–21.
4. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA. 2014; 311 (8): 806–14.
5. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014; 384 (9945): 766–81.
6. Cossrow N, Falkner B. Race/ethnic issues in obesity and obesityrelated comorbidities. J Clin Endocrinol Metab. 2004; 89 (6): 2590-4.
7. Hall V, Thomsen RW, Henriksen O, Lohse N. Diabetes in Sub-Sahara Africa 1999–2011. Epidemology and public health implications. A systemic review. BMC Public Health. 2011; 11: 564.
8. Mbanya JC, Motala AA, Sobngwi E, Assah FK, Enoru ST. Diabetes in Sub-Saharan Africa. Lancet. 2010; 375 (9733): 2254–66.
9. Ferguson TS, Tulloch-Reid MK, Wilks RJ. The epidemiology of diabetes mellitus in Jamaica and the Caribbean: a historical review. West Indian Med J. 2010; 59 (3): 259–64.
10. Amoah AG. Undiagnosed diabetes and impaired glucose regulation in adult Ghanaians using the ADA and WHO diagnostic criteria. Acta Diabetol. 2002; 39 (1): 7–13.
11. Banerji MA. Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus—BFlatbush diabetes. J Pediatr Endocrinol Metab. 2002; 15 Suppl 1: 493–501.
12. Mauvais-Jarvis F, Sobngwi E, Porcher R, et al. Ketosis-prone type 2 diabetes in patients of Sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes. 2004; 53 (3): 645–53.
13. Umpierrez GE. Ketosis-prone type 2 diabetes: time to revise the classification of diabetes. Diabetes Care. 2006; 29 (12): 2755–7.
14. Morrison EY, Ragoobirsingh D. J type diabetes revisited. J Natl Med Assoc. 1992; 84 (7): 603–8.
15. Michael S. Boyne, diabetes in the Caribbean: trouble in paradise. 4.2: 94–105. Excerpta Medica. 2009; 4: 94–105.
16. Stumvoil M, Goldstein BJ. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005; 365 (9467): 1333–3346.
17. Osei K, Rhinesmith S, Gaillard T, Schuster D. Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention. Diabetes Care. 2004; 27 (6): 1439–46.
18. Osei K, Schuster DP, Amoah AG, Owusu SK. Diabetes in Africa. Pathogenesis of type 1 and type 2 diabetes mellitus in Sub-Saharan Africa: implications for transitional populations. J Cardiovasc Risk. 2003; 10 (2): 85–96.
19. Osei K, Gaillard T, Schuster DP. Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness. Diabetes Care. 1997; 20 (3): 396–404.
20. Haffner SM, Howard G, Mayer E, et al. Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: The Insulin Resistance Atherosclerosis Study. Diabetes. 1997; 46 (1): 63–9.
21. Amoah AG, Owusu SK, Schuster DP, Osei K. Pathogenic mechanism of type 2 diabetes in Ghanaians—the importance of beta cell secretion, insulin sensitivity and glucose effectiveness. S Afr Med J. 2002; 92 (5): 377–84.
22. Osei K, Schuster DP, Owusu SK, Amoah AG. Race and ethnicity determine serum insulin and C-peptide concentrations and hepatic insulin extraction and insulin clearance: comparative studies of three populations of West African Ancestry and white Americans. Metabolism. 1997; 46 (1): 53–8.
23. Carnethon MR, Palaniappan LP, Burchfiel CM, Brancati FL, Fortmann SP. Serum insulin, obesity and the incidence of type 2 diabetes in black and white adults. Atherosclerosis Risk in the Community (ARIC) 1987–1998. Diabetes Care. 2002; 25 (8): 1358–64.
24. Bacha F, Lee S, Gungor N, Arslanian SA. From prediabetes to type 2 diabetes in obese youth: pathophysiological characteristics among the spectrum of glucose dysregulation. Diabetes Care. 2010; 33 (10): 2225–31.
25. Bacha F, Gungor N, Lee S, Arslanian SA. Type 2 diabetes in youth: are there racial differences in beta cell responsiveness relative insulin sensitivity. Pediatr Diabetes. 2012; 13 (3): 259–65.
26. D’Adamo E, Caprio S. Type 2 diabetes in youth: epidemiology and pathophysiology. Diabetes Care. 2011; 34 Suppl 2: S161–5.
27. Haffner S, D’Agostino S, Saad M, Rewers M, Mykkanen L, Selby J, et al. Increased insulin resistance and insulin secretion in nondiabetic African Americans and Hispanics compared to non-Hispanic Whites: the Insulin Resistance Atherosclerosis Study. Diabetes. 1996; 45: 742–8.
28. Osei K, Schuster DP. Ethnic differences in secretion, sensitivity, and hepatic extraction of insulin in black and white Americans. Diabet Med. 1994; 11 (8): 755–62.
29. Amoah AG, Owusu SK, Ayittey OM, Schuster DP, Osei K. Minimal model analyses of beta cell secretion, insulin sensitivity and glucose effectiveness in glucose tolerant, non-diabetic first-degree relatives of Ghanaian patients with type 2 diabetes and healthy control subjects. Ethn Dis. 2001; 11 (2): 201–10.
30. Lee CC, Haffner SM, Wagenknecht LE, Lorenzo C, Norris JM, Bergman RN, et al. Insulin clearance and the incidence of type 2 diabetes in Hispanics and African Americans: the IRAS family study. Diabetes Care. 2013; 36 (4): 901–7.
31. Harris MI, Cowie CC, Gu K, Francis ME, Flegal K, Eberhardt MS. Higher fasting insulin but lower fasting C-peptide levels in African Americans in the US population. Diabetes Metab Res Rev. 2002; 18 (2): 149–55.
32. Osei K, Cottrell DA, Harris B. Differences in basal and poststimulation glucose homeostasis in nondiabetic first degree relatives of black and white patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 1992; 75 (1): 82–6.
33. Ellis AC, Alvarez JA, Granger WM, Ovalle F, Gower BA. Ethnic differences in glucose disposal, hepatic insulin sensitivity, and endogenous glucose production among african american and european american women. Metabolism. 2012; 61 (5): 634–40.
34. Hoffman R. Increased fasting triglyceride levels are associated with hepatic insulin resistance in Caucasians and not African American adolescents. Diabetes Care. 2006; 29 (6): 1402–4.
35. DeLany JP, Dubé JJ, Standley RA, Distefano G, Goodpaster BH, Stefanovic-Racic M, et al. Racial differences in peripheral insulin sensitivity and mitochondrial capacity in the absence of obesity. J Clin Endocrinol Metab. 2014; 99 (11): 4307–14.
36. Choukem SP, Sobngwi E, Fetita LS, Boudou P, De Kerviler E, Boirie Y, et al. Multitissue insulin resistance despite nearnormoglycemic remission in Africans with ketosis-prone diabetes. Diabetes Care. 2008; 31 (12): 2332–7.
37. Guerrero R, Vega GL, Grundy SM, Browning JD. Ethnic differences in hepatic steatosis. An insulin resistance paradox? Hepatology. 2009; 49 (3): 791–801.
38. Deboer MD, Wiener RC, Barnes BH, Gurka MJ. Ethnic differences in the link between insulin resistance and elevated ALT. Pediatric. 2013; 132 (3): e718–26.
39. Gaillard T, Schuster D, Osei K. Differential impact of serum glucose, triglycerides and HDL-C on cardiovascular risk factor burden in nondiabetic, obese African American Women: implications for the prevalence of metabolic syndrome. Metabolism. 2010; 59 (8): 1115–23.
40. Meis SB, Schuster D, Gaillard T, Osei K. Metabolic syndrome in non-diabetic, obese first degree relatives of African American patients with type 2 diabetes. African American triglycerides-HDLand insulin resistance paradox. Ethn Dis. 2006; 16: 830–6.
41. Gaillard T, Parthasarathy S, Osei K. HDL dysfunctionality (paraoxonase) is worse in nondiabetic, postmenopausal African American than in white women. Diabetes Care. 2011; 34 (2): e19-e1189. doi: 10.2337/dc10-1189.
42. Sumner AE, Finley KB, Genovese DJ, Criqui M, Boston R. Fasting triglycerides and the triglyceride-HDL-cholesterol ratio are not markers of insulin resistance in African Americans. Arch Intern Med. 2005; 165: 1395–400.
43. Cowie CC, Howard BV, Harris MI. Serum lipoproteins in African Americans and whites with non-insulin-dependent diabetes in the US population. Circulation. 1991; 90: 1185–93.
44. Li C, Ford ES, Meng YX, Mokdad AH, Reaven GM. Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity? Cardiovasc Diabetol. 2008; 7: 4.
45. Tillin T, Forouhi N, Johnson DG, McKeiggue PM, Chaturvedi N, Godsland IF. Metabolic Syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study. Diabetologia. 2005; 48: 649–56.
46. Ukegbu UJ, Castillo DC, Knight MG, Ricks M, Miller 3rd BV, Onumah BM, et al. Metabolic syndrome does not detect risk in African men living in the US. Diabetes Care. 2011; 34 (10): 2297–9.
47. Wang L, Sacks FM, Furtado JD, Ricks M, Courville AB, Sumner AE. Racial differences between African American and white women in insulin resistance and visceral adiposity are associated with differences in apoCIII containing ApoA1 and apoB lipoproteins. Nutr Metab. 2014; 11 (1): 56.
48. Crowther NJ, Ferris WF, Ojwang PJ, Rheeder P. The effect of abdominal obesity on insulin sensitivity and serum lipid and cytokine concentrations in African women. Clin Endocrinol (Oxf). 2006; 64 (5): 535–41.
49. Osei K, Gaillard T, Schuster D. Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes. Obes Res. 2005; 13 (1): 179–85.
50. Hanley AJ, Wagenknecht LE, Norris JM, Bergman R, Anderson A, Chen YI, et al. Adiponectin and the incidence of type 2 diabetes in Hispanics and African Americans: the IRAS family study. Diabetes Care. 2011; 34 (10): 2231–6.
51. Martinez Cantarin MP, Keith SW, Deloach S, Huan Y, Falkner B. Relations of adiponectin and insulin sensitivity in African Americans. Am J Med Sci. 2011; 342 (3): 192–7.
52. Ferris WF, Naran NH, Crowther NJ, Rheeder P, van der Merwe L, Chetty N. The relationship between insulin sensitivity and serum adiponectin levels in three population groups. Horm Metab Res. 2005; 37 (11): 695–701.
53. Degawa-Yamauchi M, Dilts JR, Bovenkerk JE, Saha C, Pratt JH, Considine RV. Lower serum adiponectin levels in African-American boys. Obes Res. 2003; 11 (11): 1384–90.
54. Bacha F, Saad R, Gungor N, Arslanian SA. Does adiponectin explain the lower insulin sensitivity and hyperinsulinemia of African-American children? Pediatr Diabetes. 2005; 6 (2): 100–2.
55. McCormack S, Grant SFA. Genetics of obesity and type 2 diabetes in African Americans. J Obes. 2013; 2013: 396416.
56. Rotimi CN, Dunston GM, Berg K, Akinsete O, Amoah A, Owusu S, et al. In search of susceptibility genes for type 2 diabetes inWest Africa: the design and results of the first phase of the AADMstudy. Ann Epidemiol. 2001; 11 (1): 51–8.
57. Chen Y, Kittles R, Zhou J, Chen G, Adeyemo A, Panguluri RK, et al. Calpain-10 gene polymorphisms and type 2 diabetes in west Africans: the Africa America Diabetes Mellitus (AADM) Study. Ann Epidemiol. 2005; 15 (2): 153–9.
58. Chen G, Bentley A, Adeyemo A, Shriner D, Zhou J, Doumatey A, et al. Genome-wide association study identifies novel loci association with fasting insulin and insulin resistance in African Americans. Hum Mol Genet. 2012; 21 (20): 4530–6.
59. Yan Y, North KE, Heiss G, Klein R, Girman CJ, Lange EM, et al. Transcription factor 7-like 2 (TCF7L2) polymorphism and contextspecific risk of impaired fasting glucose in African American and Caucasian adults: the atherosclerosis risk in communities (ARIC) study. Diabetes Metab Res Rev. 2010; 26 (5): 371–7.
60. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. Creactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001; 286 (3): 327–34.
61. Ford ES, Giles WH, Mokdad AH, Myers GL. Distribution and correlates of C-reactive protein concentrations among adult US women. Clin Chem. 2004; 50 (3): 574–81.
62. Hyatt TC, Phadke RP, Hunter GR, Bush NC, Munoz AJ, Gower BA. Insulin sensitivity in African-American and white women: association with inflammation. Obesity (Silver Spring). 2009; 17 (2): 276–82.
63. Wee CC, Mukamal KJ, Huang A, Davis RB, McCarthy EP, Mittleman MA. Obesity and C-reactive protein levels among white, black, and Hispanic US adults. Obesity (Silver Spring). 2008; 16 (4): 875–80.
64. Carroll JF, Fulda KG, Chiapa AL, Rodriquez M, Phelps DR, Cardarelli KM, et al. Impact of race/ethnicity on the relationship between visceral fat and inflammatory biomarkers. Obesity (Silver Spring). 2009; 17 (7): 1420–7.
65. Schutte AE, van Vuuren D, van Rooyen JM, Huisman HW, Schutte R, Malan L, et al. Inflammation, obesity and cardiovascular function in african and caucasian women from South Africa: the POWIRS study. J Hum Hypertens. 2006; 20 (11): 850–9.
66. Lefebvre P. Ketosis-prone atypical diabetes: glucagon is there, too. Diabetes Care. 2013; 36 (1): 8–10.
67. Fernendez JR, Shriver MD, Beasley TM, et al. Association of African genetic admixture with resting metabolic rate and obesity among women. Obes Res. 2003; 7: 904–11.
68. Kimm SYS, Glynn NW, Aston CE, Poelman ET, Daniels SR, Ferrell RE. Racial differences in the relation between uncoupling protein genes and resting energy expenditure. Am J Clin Nutr. 2002; 75 (4): 714–9.
69. Dabelea D, Dolan LM, D’Agostino Jr R, Hernandez AM, McAteer JB, Hamman RF, et al. Association testing of TCF7L@ polymorphisms with type 2 diabetes in multi-ethnic youth. Diabetologia. 2011; 54 (3): 535–9.
70. Danquah I, Othmer T, Frank LK, Bedu-Addo G, Schulze M, Mockenhaupt FP. The TCF7L2 rs7903146 (T) allele is associated with type 2 diabetes in urban Ghana: a hospital-based case–control study. BMC Med Genet. 2013; 14: 96. doi: 10.1186/1471-2350-14-96.
71. Palmer ND, Hester JM, An SS, Adeyemo A, Rotimi C, Langefeld CD, et al. Resequencing and analysis of variation in the TCF7L2 in African Americans suggest that SNP RS7903146 is the causal diabetes susceptibility variant. Diabetes. 2011; 60 (2): 662–8.
72. Cheng CY, Reich D, Haiman CA, Tandon A, Patterson N, Selvin E, et al. African ancestry and its correlation to type 2 diabetes in African Americans: a genetic admixture analysis in three US population cohorts. PLoS One. 2012; 7 (3): e32840.
73. Crowther NJ, Cameron N, Trusler J, Gray IP. Association between poor glucose tolerance and rapid post natal weight gain in sevenyear-old children. Diabetologia. 1998; 41 (10): 1163–7.
74. Gray IP, Cooper PA, Cory BJ, Toman M, Crowther NJ. The intrauterine environment is a strong determinant of glucose tolerance during the neonatal period, even in prematurity. J Clin Endocrinol Metab. 2002; 87 (9): 4252–6.
75. Umpierrez GE, Woo W, Hagopian WA, Isaacs SD, Palmer JP, Gaur LK, et al. Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care. 1999; 22 (9): 1517–23.
76. Umpierrez GE, Smiley D, Robalino G, Peng L, Gosmanov AR, Kitabchi AE. Lack of lipotoxicity: effect on beta cell dysfunction in ketosis prone type 2 diabetes. Diabetes Care. 2010; 33 (3): 626–31.